Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial

Table 1 Patients’ demographic characteristics

Variable	Surfactant with N.S. (n = 24)	Surfactant with Salb. (n = 24)	p
G. age (week)	29.70 ± 2.27	30.04 ± 2.07	0.59
B.B.W (g)	1430.83 ± 393.41	1443 ± 267.22	0.89
Gender
M.	15(62.5 %)	17(70.8 %)	0.54
F.	9(37.5 %)	7(29.2 %)	0.54
Delivery
C.S.	18(75 %)	19(79.2 %)	0.73
Vag.	6(25 %)	5(20.8 %)	0.73
Perenatal steroid
Yes	11(45.8 %)	10(41.7 %)	0.77
No	13(54.2 %)	14(58.3 %)	0.77
Curosurf dosage
1	20(83.3 %)	18(75 %)	0.47
2	4(16.7 %)	6(25 %)	0.47

N.S normal saline, Salb salbutamol, G gestational, B.B.W birth body weight, M male, F female, C.S cesarean section, Vag vaginal

ISSN: 1824-7288